Cite
MLA Citation
Andrew B Lassman et al.. “Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.” Neuro-oncology, vol. 21, no. 1, 2019, pp. 106–114. http://access.bl.uk/ark:/81055/vdc_100094046641.0x000016